Inhibition of cloned hERG potassium channels by risperidone and paliperidone

Risperidone and one of its active metabolites, paliperidone, are widely used for the treatment of schizophrenia. We used a patch-clamp study to investigate the effects of paliperidone on hERG potassium channels expressed in HEK cells. Western blot analyses were used to study the effects of risperidone and paliperidone on hERG and hERG 3.1 isoform channel trafficking. Risperidone and paliperidone inhibited the hERG tail currents in a concentration-dependent manner with IC50 values of 0.16 and 0.57 μM, respectively. The block of hERG currents by paliperidone was voltage-dependent, increasing over a range of voltages for channel activation. A fast application of paliperidone inhibited the hERG current elicited by a 5-s depolarizing pulse to +60 mV to fully inactivate the hERG currents, suggesting an inactivated state block. A fast application of paliperidone during repolarization reversibly inhibited the hERG tail currents in a concentration-dependent manner with a IC50 value of 1.26 μM. Kinetic analysis of paliperidone interaction with the open state of the hERG channels showed that the rate constants of association (k+1) and dissociation (k−1) for paliperidone were 0.45 μM−1 s−1 and 1.07 s−1, respectively. Paliperidone shifted the steady-state inactivation curve of the hERG currents in a hyperpolarizing direction and also produced a use-dependent block. Risperidone and paliperidone had no effect on hERG and hERG 3.1 channel trafficking to the cell membrane. Our results indicated that paliperidone inhibited the hERG current by preferentially interacting with the open and inactivated states of the channel, but not by disruption of hERG channel protein trafficking.

[1]  C. Canavier,et al.  Ether-a-go-go-related gene potassium channels: what's all the buzz about? , 2006, Schizophrenia bulletin.

[2]  J. Levenson,et al.  Fatal Cardiac Event following Initiation of Risperidone Therapy , 1997, The Annals of pharmacotherapy.

[3]  K. Cheng,et al.  Effects of paliperidone extended release on the symptoms and functioning of schizophrenia , 2012, BMC clinical pharmacology.

[4]  D. Rujescu,et al.  A novel, primate-specific, brain isoform of KCNH2 impacts cortical physiology, cognition, neuronal repolarization and risk for schizophrenia , 2009, Nature Medicine.

[5]  J. Barrow,et al.  Schizophrenia-Associated hERG channel Kv11.1-3.1 Exhibits a Unique Trafficking Deficit that is Rescued Through Proteasome Inhibition for High Throughput Screening , 2016, Scientific Reports.

[6]  D. Snyders,et al.  Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. , 1995, Circulation research.

[7]  M. Papa,et al.  Expression pattern of the ether‐a‐gogo‐related (ERG) k+ channel‐encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system , 2003, The Journal of comparative neurology.

[8]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[9]  M. Kamalesh,et al.  Effect of risperidone on QT interval and QT dispersion in the elderly. , 2000, Heart disease.

[10]  U. Ravens,et al.  Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of ICa,L , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  A H Glassman,et al.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.

[12]  Expression of KCNH2-3.1 mRNA is increased in small neurons in the dorsolateral prefrontal cortex in patients with schizophrenia , 2015 .

[13]  J. Hancox,et al.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine , 2002, British journal of pharmacology.

[14]  E. Snoeck,et al.  The pharmacokinetics of risperidone in humans: a summary. , 1994, The Journal of clinical psychiatry.

[15]  Yun Ju Chae,et al.  Escitalopram block of hERG potassium channels , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  F. Henretig,et al.  Effects of risperidone in overdose. , 1998, The American journal of emergency medicine.

[17]  S. Leffler,et al.  Overdose of risperidone. , 1993, Annals of emergency medicine.

[18]  B. Fermini,et al.  Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. , 1995, The Journal of pharmacology and experimental therapeutics.

[19]  J. de Leon,et al.  The pharmacokinetics of paliperidone versus risperidone. , 2010, Psychosomatics.

[20]  Jacques Caron,et al.  Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes. , 2002, European journal of pharmacology.

[21]  D. Roden,et al.  Risperidone Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current , 2003, Journal of cardiovascular pharmacology.

[22]  Se-Won Lim,et al.  Effectiveness of paliperidone extended‐release for patients with schizophrenia: focus on subjective improvement , 2013, Human psychopharmacology.

[23]  N. Moore,et al.  Risperidone overdose , 2012, Reactions Weekly.

[24]  Yun Ju Chae,et al.  Effects of donepezil on hERG potassium channels , 2015, Brain Research.

[25]  B. Drolet,et al.  Prolongation of Cardiac Ventricular Repolarization Under Paliperidone: How and How Much? , 2011, Journal of cardiovascular pharmacology.

[26]  D. Snyders,et al.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.

[27]  R. Hales,et al.  Pharmacologic approach to management of agitation associated with dementia. , 1994, The Journal of clinical psychiatry.

[28]  C. Valdivia,et al.  Drug‐induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine , 2006, British journal of pharmacology.

[29]  Jaskaran Singh,et al.  A Randomized, Double-Blind Study of Paliperidone Extended-Release in Treatment of Acute Schizophrenia in Adolescents , 2011, Biological Psychiatry.

[30]  D. Owens.  The spectrum of depressive phenomena after spousal bereavement. , 1994 .

[31]  C. Antzelevitch.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[32]  Steffen Hering,et al.  State-dependent dissociation of HERG channel inhibitors , 2007, British journal of pharmacology.

[33]  In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone. , 2002, Toxicology and applied pharmacology.

[34]  Stefan A. Mann,et al.  The Schizophrenia-Associated Kv11.1-3.1 Isoform Results in Reduced Current Accumulation during Repetitive Brief Depolarizations , 2012, PloS one.

[35]  Jules C Hancox,et al.  The hERG potassium channel and hERG screening for drug-induced torsades de pointes. , 2008, Pharmacology & therapeutics.

[36]  M. Schwarz,et al.  Serum concentrations of paliperidone versus risperidone and clinical effects , 2010, European Journal of Clinical Pharmacology.

[37]  Gary A Gintant,et al.  Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety , 2006, Toxicologic pathology.

[38]  Candace S. Brown,et al.  Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy , 1999, The Annals of pharmacotherapy.

[39]  Melissa J. Green,et al.  Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status. , 2015, The American journal of psychiatry.

[40]  D. Gardner,et al.  A case of risperidone overdose in early schizophrenia: a review of potential complications. , 1998, Journal of psychiatry & neuroscience : JPN.

[41]  W. Zareba,et al.  Antipsychotic Drugs and QT Interval Prolongation , 2004, Psychiatric Quarterly.

[42]  M. Kester,et al.  State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy. , 2009, American journal of physiology. Cell physiology.

[43]  D. Grandmougin,et al.  Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium. , 2004, European journal of pharmacology.